GSK2820151
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK2820151, covering 2020-02-12 to 2020-02-12. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation Study of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors [Phase 1]